# Chromium(VI) Modulates Macrophage Polarization and Metabolic Reprogramming to Impair Immune Function

**Authors:** Cheng Li, Ruihang Zhang, Yuhan Zhang, Hongxi Yu, Yu Zheng, Yifei Du, Shiyi Hong, Lihua Hu, Chaoyang Wang, Guang Jia, Guiping Hu

PMC · DOI: 10.3390/toxics14020160 · 2026-02-08

## TL;DR

Chromium(VI) exposure alters macrophage function and metabolism, leading to immune dysfunction and environmental health risks.

## Contribution

This study reveals how Cr(VI) induces M1 polarization and metabolic reprogramming in macrophages, impairing immune function.

## Key findings

- Cr(VI) exposure increases M1 markers like TNF-α, CD36, and CD80 while decreasing M2 marker VEGFb.
- Cr(VI) impairs ATP production and shifts macrophage metabolism toward glycolysis despite increased glucose uptake.
- Mitochondrial damage and oxidative stress are observed, contributing to Cr(VI)-induced immunotoxicity.

## Abstract

Hexavalent chromium (Cr(VI)) is a recognized environmental and occupational hazard with significant implications for immune function. However, the cell-intrinsic mechanisms by which Cr(VI) coordinately reshapes macrophage polarization together with immunometabolic and mitochondrial alterations remain incompletely characterized. This study investigated how Cr(VI) exposure influences macrophage morphology, polarization, energy metabolism, and mitochondrial integrity using an in vitro model. Macrophages exposed to Cr(VI) exhibited morphological changes, including pseudopod growth and fusiform shapes, alongside a shift toward M1-type polarization. Key M1 associated biomarkers, including TNF-α, CD36, and CD80, increased 24 h after Cr(VI) exposure, whereas the M2 associated VEGFb decreased. Cr(VI) exposure also impaired energy metabolism, reducing ATP production and shifting metabolism towards glycolysis, despite increased glucose uptake. Mitochondrial damage, membrane potential collapse, and elevated oxidative stress further highlighted the immunotoxic effects of Cr(VI). Cr(VI) exposure may drive a metabolic shift in macrophages toward less efficient energy production pathways, such as glycolysis. These findings provide critical insights into Cr(VI)-induced macrophage dysfunction and emphasize the environmental risks associated with Cr(VI) pollution, underscoring the need for further mechanistic research and mitigation strategies to safeguard public health.

## Linked entities

- **Proteins:** TNF (tumor necrosis factor), CD36 (CD36 molecule (CD36 blood group)), CD80 (CD80 molecule), VEGFB (vascular endothelial growth factor B)
- **Chemicals:** Chromium(VI) (PubChem CID 29131), Cr(VI) (PubChem CID 29131)

## Full-text entities

- **Genes:** Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il23a (interleukin 23, alpha subunit p19) [NCBI Gene 83430] {aka IL-23, p19}, Scgb1a1 (secretoglobin, family 1A, member 1) [NCBI Gene 22287] {aka CC10, CC16, CCSP, PCB-BP, UG, UGB}, Slc2a1 (solute carrier family 2 (facilitated glucose transporter), member 1) [NCBI Gene 20525] {aka GT1, Glut-1, Glut1, M100200, Rgsc200}, Hif1a (hypoxia inducible factor 1, alpha subunit) [NCBI Gene 15251] {aka HIF-1-alpha, HIF1-alpha, HIF1alpha, MOP1, bHLHe78}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, Blnk (B cell linker) [NCBI Gene 17060] {aka BASH, Bca, Ly-57, Ly57, Lyw-57, SLP-65}
- **Diseases:** allergic reactions (MESH:D004342), carcinogenic (MESH:D011230), cytotoxicity (MESH:D064420), neurological and cardiovascular diseases (MESH:D002318), organ failure (MESH:D009102), genetic damage (MESH:D030342), mitochondrial (MESH:D028361), injury to (MESH:D014947), inflammation (MESH:D007249), mitochondrial disruption (MESH:D019958), asthma (MESH:D001249), cancer (MESH:D009369)
- **Chemicals:** Lipid (MESH:D008055), Calcein (MESH:C007740), ATP (MESH:D000255), CO2 (MESH:D002245), Glucose (MESH:D005947), heavy metal (MESH:D019216), ROS (MESH:D017382), oxides (MESH:D010087), glutaraldehyde (MESH:D005976), PBS (MESH:D007854), PVDF (MESH:C024865), JC-1 (MESH:C068624), penicillin (MESH:D010406), Chemicals (-), 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (MESH:C098340), MDA (MESH:D008315), fatty acid (MESH:D005227), Cr (MESH:D002857), DCFH-DA (MESH:C029569), CCK-8 (MESH:D012844), water (MESH:D014867), SDS (MESH:D012967), K2Cr2O7 (MESH:D011192), PI (MESH:D010716), oxygen (MESH:D010100), Cr(VI (MESH:C074702), phalloidin (MESH:D010590), stainless steel (MESH:D013193), itaconate (MESH:C005229), calcein-AM (MESH:C085925), Succinate (MESH:D019802), chromate (MESH:D002840), TCA (MESH:D014233), 2',7'-dichlorodihydrofluorescein diacetate (MESH:C110400), streptomycin (MESH:D013307), pentose phosphate (MESH:D010428), FITC (MESH:D016650), CCCP (MESH:D002258)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** C015M, S0033M
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), RAW264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), CCK-8 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_2873)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12944406/full.md

---
Source: https://tomesphere.com/paper/PMC12944406